drugset / Trial / NCT07317206

Ayahuasca, Esketamine and PTSD

NCT07317206

Phase 2 Recruiting 10 enrolled University of Sao Paulo
RandomizedParallel-groupDouble-blindTreatment

Summary

Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.

Timeline

Start
2025-12-20
Primary completion
2026-06
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ayahuasca Traditional medicine (herbal / TCM) Oral
Comparator Esketamine Other / unclassified Oral